Home›Stocks›IBO

IBO — structural market context

Impact BioMedical, Inc.

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

What changed

As of the close on Oct 21. Each line shows the earlier value, the later value and their dates.

Price

Close $4.02 (Oct 21) vs $3.27 (Oct 20): +23.03%.

Volume

1.74× its 20-session average (16K) on Oct 21.

Includes pre- and post-market trading.

Short interest

Short interest 30K shares (settlement Sep 30) vs 527K (Sep 15).

No new publication in this window. Latest: settlement Sep 30, published Oct 10.

Fails-to-deliver

Latest file (settlements Sep 15–Sep 30, published Oct 16): 11 days with fails, largest 8K shares on Sep 18.

Previous file (settlements Sep 1–Sep 14, published Sep 30): 5 days with fails, largest 2K shares on Sep 14.

No new publication in this window.

Insider filings (Form 4)

None recorded in this window.

IBO short interest & days to cover

SHARES SHORT
30K
% OF FLOAT
0.4%
DAYS TO COVER
2.0
CHANGE VS PRIOR
-94.3%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-09-30 (22d ago)

IBO fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-09-30 · 22d346$5.6
2026-09-29 · 23d397$5.61
2026-09-28 · 24d224$5.69

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

IBO insider buying and selling (Form 4)

Last 12 months, Form 4 codes P and S: 0 purchases · 3 sales

InsiderTypeSharesValueFiled
DSS, INC. · 10 percent ownerSale (S)723$3982026-09-24
DSS, INC. · 10 percent ownerSale (S)27$1882026-09-24
DSS, INC. · 10 percent ownerSale (S)156$1K2026-09-24

SEC Form 4 filings: purchases and sales reported on Form 4 (transaction codes P and S) only; grants and option exercises excluded. Attributed public records.

Frequently asked questions

What is IBO's short interest?
As of the FINRA settlement date 2026-09-30, IBO had 30K shares sold short — 0.4% of its float, with 2.0 days to cover at average volume. FINRA publishes this data roughly two weeks after each twice-monthly settlement, so it is inherently delayed. A short-interest figure describes an aggregate position; it does not predict what the stock will do.
Are insiders buying IBO?
In the last 12 months of SEC Form 4 filings, IBO recorded 0 insider purchases and 3 sales reported on Form 4 (transaction codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.
Is this page telling me to buy or sell IBO?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with I

IAG · IAMGold CorporationIBKR · Interactive Brokers Group, IncIBP · INSTALLED BUILDING PRODUCTS, IICL · ICL Group Ltd.IDT · IDT CorporationIDXX · IDEXX Laboratories, Inc.All I →

IBO: the full history

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.